197 related articles for article (PubMed ID: 6145472)
21. Platelet alpha-2 adrenoceptor-mediated primary aggregation and adenylate cyclase inhibition in depressed patients.
Karege F; Bovier P; Hilleret H; Gaillard JM
Lancet; 1993 Apr; 341(8851):1029. PubMed ID: 8096917
[No Abstract] [Full Text] [Related]
22. Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.
Amirrasooli H; Mac Neil S; Tomlinson S
Br J Pharmacol; 1981 Jul; 73(3):639-47. PubMed ID: 7248663
[TBL] [Abstract][Full Text] [Related]
23. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
24. Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
Gorman RR; Bunting S; Miller OV
Prostaglandins; 1977 Mar; 13(3):377-88. PubMed ID: 191876
[TBL] [Abstract][Full Text] [Related]
25. The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes.
Stein JM; Martin BR
Biochem J; 1983 Jul; 214(1):231-4. PubMed ID: 6684425
[TBL] [Abstract][Full Text] [Related]
26. The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.
Spence S; Houslay MD
Biochem J; 1989 Dec; 264(2):483-8. PubMed ID: 2557841
[TBL] [Abstract][Full Text] [Related]
27. Decrease in epinephrine-induced attenuation of platelet adenylate cyclase activity in depressed patients: relation with plasma electrolytes.
Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
Neuropsychobiology; 1992; 26(3):129-35. PubMed ID: 1338221
[TBL] [Abstract][Full Text] [Related]
28. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
29. Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.
Jakobs KH; Bauer S; Watanabe Y
Eur J Biochem; 1985 Sep; 151(2):425-30. PubMed ID: 4040856
[TBL] [Abstract][Full Text] [Related]
30. Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.
Jakobs KH; Saur W; Schultz G
Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):285-91. PubMed ID: 26887
[No Abstract] [Full Text] [Related]
31. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect.
Rao AK; Willis J; Kowalska MA; Wachtfogel YT; Colman RW
Blood; 1988 Feb; 71(2):494-501. PubMed ID: 2827817
[TBL] [Abstract][Full Text] [Related]
32. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
33. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
Yokota S; Hikasa Y; Mizushima H
Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
[TBL] [Abstract][Full Text] [Related]
34. Forskolin sensitizes human platelet adenylate cyclase to modulation of substrate (MgATP) affinity by hormones.
Watanabe Y; Jakobs KH
Biochem J; 1986 Jul; 237(1):273-6. PubMed ID: 3492195
[TBL] [Abstract][Full Text] [Related]
35. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
37. Critical assessment of the platelet adenylate cyclase system as a potential model for testing alpha 2 adrenergic activity.
Ferry N; Henry D; Battais E; Mary A; Bonne C; Hanoune J
Biochem Pharmacol; 1986 May; 35(9):1511-6. PubMed ID: 2871841
[TBL] [Abstract][Full Text] [Related]
38. Platelets in nonresponders to epinephrine stimulation showed reduced response to ADP.
Nakahashi TK; Kambayashi J; Nakamura T; Le SN; Yoshitake M; Tandon NN; Sun B
Thromb Res; 2001 Oct; 104(2):127-35. PubMed ID: 11672756
[TBL] [Abstract][Full Text] [Related]
39. Heparin uncouples alpha 2-adrenoceptors from the Gi-protein in membranes of human platelets.
Willuweit B; Aktories K
Biochem J; 1988 Feb; 249(3):857-63. PubMed ID: 2833229
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
